Want to see CH:ALC full AI Analyst Report?

Alcon (ALC) Price & Analysis

17 Followers

ALC Stock Chart & Stats

CHF55.74

-CHF0.06(-0.11%)

At close: Jul 27 4:00 PM EDT

CHF55.74

-CHF0.06(-0.11%)

Day’s Range― - ―

52-Week RangeCHF47.80 - CHF72.88

Previous CloseN/A

Volume1.70M

Average Volume (3M)1.46M

Market Cap

CHF28.65B

Enterprise ValueCHF31.95K

Total Cash (Recent Filing)CHF1.66B

Total Debt (Recent Filing)CHF5.25B

Price to Earnings (P/E)44.4

Beta1.05

Next Earnings

Nov 10, 2026

EPS Estimate

0.71

Next Dividend Ex-DateN/A

Dividend Yield0.48%

Share Statistics

EPS (TTM)1.65

Shares Outstanding499,700,000

10 Day Avg. Volume1,240,075

30 Day Avg. Volume1,456,701

Financial Highlights & Ratios

PEG Ratio39.53

Price to Book (P/B)1.79

Price to Sales (P/S)3.61

P/FCF Ratio21.75

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF71.34

Price Target Upside27.99% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering11

EPS Forecast (FY)2.76

Revenue Forecast (FY)CHF8.85B

Bulls Say, Bears Say

Bulls Say

Strong Balance SheetLow leverage and a sizable equity base provide durable financial flexibility. This containment of financial risk supports sustained R&D investment, equipment placements and shareholder returns, and cushions cyclical procedure volatility—strengthening the firm's ability to execute multi-year strategic initiatives.

Equipment Momentum And Installed Base GrowthRapid Unity adoption accelerates capital placements and expands the installed base, creating durable follow-on demand for consumables and service revenue. Strong equipment placement increases forward visibility of recurring revenue and strengthens competitive differentiation via platform-driven customer lock-in.

Recurring Vision-care Demand And Product InnovationHealthy growth in contact lenses and ocular-health products reflects stickiness and repeat purchasing. Continued product innovation (new reusable lenses, preservative-free formulations) and high refill/retention rates underpin predictable recurring revenues and improve lifetime customer value across retail and practitioner channels.

Bears Say

Free Cash Flow And Cash Conversion WeaknessA meaningful TTM FCF decline and sub-1x cash/earnings conversion weaken the company’s ability to fund capex, launches and buybacks from operating cash. Persistent cash conversion pressure would constrain capital allocation flexibility and increase reliance on financing during investment cycles.

Tariff-driven Margin PressureMaterial tariff-related cost increases compress gross margins and erode operating leverage. If tariffs or trade frictions persist, margins could remain pressured, limiting structural margin expansion from new-product mix and productivity initiatives and forcing tougher trade-offs between pricing, investment and returns.

Soft Procedure Volumes And China/competitive HeadwindsSustained softness in cataract volumes and persistent China/competitive pressure can restrain implantables and consumables growth. Structural share gains become harder amid intense competition and regional weakness, reducing topline durability and limiting the pace at which equipment-driven recurring revenue can scale.

Alcon News

Morning Movers: On Holding slips following quarterly results

Stock futures are modestly higher as investors look ahead to Wednesday’s July consumer-price report, while developments surrounding the...

7h ago

ALC

Closing Bell Movers: Upwork falls 20% after results and guidance

Equity futures are little changed in the opening hour of the evening session as narrow trading ranges established...

20h ago

Alcon reports Q2 EPS 84c, consensus 76c

Reports Q2 revenue $2.78B, consensus $2.77B. “Our team delivered strong second-quarter results and executed well across the business,”...

23h ago

ALC

Alcon raises FY26 EPS growth view to 12%-15% from 10%-13%

Consensus $3.47. Affirms FY26 revenue growth view of 5%-8%, consensus $11.13B. This outlook assumes the following: Aggregated markets...

23h ago

ALC

Alcon up 5% above $77 after Q2 results, FY26 EPS guide raise

16:44 EDT Alcon (ALC) up 5% above $77 after Q2 results, FY26 EPS guide raise Published first on...

23h ago

ALC

Alcon opens second center with Aravind Eye Care System

Aravind Eye Care System and Alcon (ALC) announced the launch of the Aravind Alcon Global Centre of Excellence...

18d ago

ALC

Alcon price target lowered to $80 from $85 at Mizuho

Mizuho lowered the firm’s price target on Alcon (ALC) to $80 from $85 and keeps an Outperform rating...

27d ago

ALC

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

David Saxon, an analyst from Needham, reiterated the Buy rating on Alcon. The associated price target is $95.00....

13h ago

ALC

Alcon Lifts 2026 Guidance After Strong Q2 Eye-Care Growth

An announcement from Alcon ( ($CH:ALC) ) is now available. Alcon reported second-quarter 2026 results on August 10,...

22h ago

ALC

ALC Earnings this Week: How Will it Perform?

Alcon (ALC) is scheduled to report 2nd quarter earnings on 08/10/2026, after the market closes. Regarding Q2 estimates,...

3d ago

ALC

Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48

In a report released today, Julien Ouaddour from Bank of America Securities reiterated a Sell rating on Alcon,...

21d ago

ALC

Alcon, RxSight enter non-exclusive pact to develop adjustable PCIOLs

Alcon (ALC) and RxSight (RXST) announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses, or PCIOLs....

1M ago

ALC

RXST

Alcon, RxSight announce collaboration to develop adjustable PCIOLs

The firm states: “Alcon (ALC) and RxSight (RXST) announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular...

1M ago

ALC

RXST

Alcon price target lowered to $85 from $90 at Argus

Argus lowered the firm’s price target on Alcon (ALC) to $85 from $90 and keeps a Buy rating...

1M ago

ALC

ALC FAQ

What was Alcon’s price range in the past 12 months?

Alcon lowest stock price was CHF47.80 and its highest was CHF72.88 in the past 12 months.

What is Alcon’s market cap?

Alcon’s market cap is CHF28.65B.

When is Alcon’s upcoming earnings report date?

Alcon’s upcoming earnings report date is Nov 10, 2026 which is in 91 days.

How were Alcon’s earnings last quarter?

Alcon released its earnings results on Aug 10, 2026. The company reported CHF0.681 earnings per share for the quarter, beating the consensus estimate of CHF0.604 by CHF0.077.

Is Alcon overvalued?

According to Wall Street analysts Alcon’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alcon pay dividends?

Alcon pays a Annually dividend of CHF0.28 which represents an annual dividend yield of 0.48%. See more information on Alcon dividends here

What is Alcon’s EPS estimate?

Alcon’s EPS estimate is 0.71.

How many shares outstanding does Alcon have?

Alcon has 499,700,000 shares outstanding.

What happened to Alcon’s price movement after its last earnings report?

Alcon reported an EPS of CHF0.681 in its last earnings report, beating expectations of CHF0.604. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Alcon?

Currently, no hedge funds are holding shares in CH:ALC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Alcon Stock Smart Score

Neutral

Fundamentals

Return on Equity

0.48%

Trailing 12-Months

Asset Growth

1.97%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Alcon

Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic surgeons with advanced solutions for various procedures. This includes specialized equipment, diagnostic instrumentation, and implantable devices such as intraocular lenses (IOLs), alongside a full suite of consumables like viscoelastic substances, surgical solutions, and customized procedure kits. For cataract interventions, key offerings feature the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA System for intra-operative measurements. Vitreoretinal surgeons benefit from systems like Constellation Vision, procedure packs, lasers, and a variety of specialized micro-instruments, including grieshaber and MIVS tools, scissors, forceps, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive surgery innovations include WaveLight lasers and Contoura Vision for LASIK treatments, and the segment also provides the EX-PRESS glaucoma filtration device. Its IOL portfolio, prominently featuring AcrySof IQ, includes advanced technology lenses like PanOptix and ReSTOR, designed to correct presbyopia and astigmatism during cataract removal. The Vision Care segment addresses everyday eye health needs. It offers a diverse selection of contact lenses, including daily disposables, reusable options, and color-enhancing varieties. This segment also provides ocular health products for conditions such as dry eye, glaucoma, and allergies, in addition to contact lens care solutions, ocular vitamins, and redness-relieving drops. Prominent brands within this segment include TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Founded in 1945, the company was initially known as Alcon Universal S.A. before rebranding as Alcon Inc. in December 2001. Its headquarters are located in Geneva, Switzerland.

Alcon (ALC) Earnings & Revenues

Historic Earnings Reports

ALC Company Deck

ALC Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call conveyed a clearly positive operational and financial quarter: 7% consolidated sales growth, strong equipment performance (UNITY), margin expansion (+250 bps gross margin, +160 bps operating margin), EPS and cash-flow strength, and multiple successful new-product introductions (PanOptix Pro, TRYPTYR, Valeda). Notable negatives included the discontinuation of the PowerVision accommodating IOL program, slower growth in implantables and certain glaucoma products, a few one-time margin items and manufacturability timing for UNITY DX. On balance, the positives — consistent revenue and margin expansion, robust cash generation and multiple high-potential product rollouts and market-share gains — outweigh the setbacks.View all CH:ALC earnings summaries

ALC Stock 12 Month Forecast

Average Price Target

CHF71.34

▲(27.99% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"47":"CHF47","57":"CHF57","67":"CHF67","77":"CHF77","87":"CHF87"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF86.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71.34007786,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF71.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF48.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[47,57,67,77,87],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,57.73538461538462,60.09076923076923,62.44615384615385,64.80153846153846,67.15692307692308,69.5123076923077,71.86769230769231,74.22307692307692,76.57846153846154,78.93384615384616,81.28923076923077,83.64461538461538,{"y":86,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,56.607698296923076,57.835396593846156,59.06309489076923,60.29079318769231,61.51849148461538,62.74618978153846,63.973888078461535,65.20158637538461,66.42928467230769,67.65698296923077,68.88468126615385,70.11237956307691,{"y":71.34007786,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.38,54.8123076923077,54.244615384615386,53.67692307692308,53.10923076923077,52.541538461538465,51.973846153846154,51.40615384615385,50.83846153846154,50.27076923076923,49.70307692307692,49.135384615384616,48.567692307692305,{"y":48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.472,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.71,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.132,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.431,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.974,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.024,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.789,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.938,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.72,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.78,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.38,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >